- Winter 2014Par Pharm., Inc. v. TWI Pharms., Inc.,
- Winter 2014Warner Chilcott Co, LLC v. Teva Pharms. USA, Inc
- Winter 2014Pfizer Inc. v. Mylan Pharms. Inc.
- Winter 2014Allergan, Inc. v. Actavis, Inc.
- Winter 2014Cubist Pharms., Inc. v. Hospira, Inc.
- Winter 2014Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc
- Winter 2014Takeda Pharms. USA, Inc. v. West-Ward Pharm. Corp.,
- February 2, 2015Five Guidelines for Renegotiating Outsourcing Contracts
- January 29, 2015A Guide to the Internet of Things
- January 29, 2015Why New Media Should Care About 'Innocence of Muslims'
- January 25, 2015Software the Supreme Court and 3D Printing
- January 23, 2015Top 5 Developments In Reverse Payments Over The Last Year
- January 23, 2015More Coverage Issues May Go To Appraisal Panels In Minn
- January 15, 2015You Cant Judge an ECF Notice by its Cover
- January 15, 2015A new cybersecurity reality for new media companies
- 2015Beyond Preemption of Generic Drug Claims
- 2015Preserving the Attorney-Client Privilege and Work-Production Protections Afforded to Communications with Experts: Be Careful of What You Say and to Whom You Say It
- 2015Strict Liability and 3D Printed Medical Devices
- December 29, 2014The 5 Intellectual Property Mistakes Startups Must Avoid to Protect ROI
- December 22, 2014The Price Intelligence Sweet Spot: Safe Data Exchange Standards to Keep You in the “Safety Zone”
- December 18, 2014How Game Developers Can Avoid Getting ‘PWN3D’ by a Right-of-Publicity Claim
- December 17, 2014Protecting Trade Secrets with a Solid Nondisclosure Agreement
- December 16, 2014Make Sure You Own the Patent You Think You Do
- December 12, 2014Are Courts the New Death Squads for Software Patents? Not So Fast.
- December 11, 2014Appellate Lawyers' New Years Resolutions
- December 5, 201410 Ways to Squeeze More Value Out of Your Legal Costs
- December 4, 2014Prospects and Problems Associated With Technological Change in Appellate Courts: Envisioning the Appeal of the Future
- December 3, 2014The Other IP Trade Secret Law and 3D Printing
- December 2, 2014Arbitration vs. Jury Trials: Does it Make a Difference?
- December 1, 2014The Internet of (Legal) Things
- November 19, 2014What Courts Consider When Deciding E-Discovery Cost Awards
- Generic Launches Q4 2012
- November 17, 2014The Maker Community and IP: Lessons From the Digital Millennium Copyright Act
- November 14, 2014Patent Litigation and Generic Drug Companies: How to Avoid Becoming an “Exceptional Case”
- November 14, 2014Five Tips for Avoiding Pitfalls in Multi-Sourcing Arrangements
- November 13, 2014A Cautionary Tale for Universities about Patent Ownership Rights from the Lone Star State
- November 13, 2014Who Says So? The Court—Or Does It?
- November 10, 2014Why Canada’s Anti-Spam Legislation (CASL) Matters to Businesses in the U.S.
- 2014The High Cost of Efficiency: Courthouse Tech and Access to Justice
- Recent Developments in Securities Law
- 5 Takeaways From FTC Actions Against Professional Boards
- November 3, 2014Expectations, Budgets and What You Should Expect Outside Counsel to do Without Even Asking
- October 29, 20143D Printing and Patents: IP Law and the Next Disruptive Technology
- Surviving Inter Partes Review: Good Experts Are Key
- When Is A Party Appointed Appraiser Disinterested
- 3-2-1? What kind of decision is that?
- October 14, 2014A Guide To Understanding Fed Circs VirnetX Opinion
- Secondary Considerations of Nonobviousness at the PTAB: Approaches and Obstacles Before the Final Written Decision
- PTAB Prohibition on Incorporation by Reference: Avoiding and Responding to Rule 42.6(a)(3) Violations
- October 8, 20143D Printing: Potential Patent Law Problems, Other IP Law Protections
